Read + Share
Amedeo Smart
Independent Medical Education
Cooper ME, van Raalte DH. GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity. J Clin Invest 2025;135:e194749.PMID: 41178712
Email
LinkedIn
Privacy Policy